Abstract:Heart disease involves irreversible myocardial injury that leads to high morbidity and mortality rates. Numerous cell-based cardiac in vitro models have been proposed as complementary approaches to non-clinical animal research. However, most of these approaches struggle to accurately replicate adult human heart conditions, such as myocardial infarction and ventricular remodeling pathology. The intricate interplay between various cell types within the adult heart, including cardiomyocytes, fibroblasts, and endothelial cells, contributes to the complexity of most heart diseases. Consequently, the mechanisms behind heart disease induction cannot be attributed to a single-cell type. Thus, the use of multi-cellular models becomes essential for creating clinically relevant in vitro cell models. This study focuses on generating self-organizing heart organoids (HOs) using human-induced pluripotent stem cells (hiPSCs). These organoids consist of cardiomyocytes, fibroblasts, and endothelial cells, mimicking the cellular composition of the human heart. The multi-cellular composition of HOs was confirmed through various techniques, including immunohistochemistry, flow cytometry, q-PCR, and single-cell RNA sequencing. Subsequently, HOs were subjected to hypoxia-induced ischemia and ischemia-reperfusion (IR) injuries within controlled culture conditions. The resulting phenotypes resembled those of acute myocardial infarction (AMI), characterized by cardiac cell death, biomarker secretion, functional deficits, alterations in calcium ion handling, and changes in beating properties. Additionally, the HOs subjected to IR efficiently exhibited cardiac fibrosis, displaying collagen deposition, disrupted calcium ion handling, and electrophysiological anomalies that emulate heart disease. These findings hold significant implications for the advancement of in vivo-like 3D heart and disease modeling. These disease models present a promising alternative to animal experimentation for studying cardiac diseases, and they also serve as a platform for drug screening to identify potential therapeutic targets.

The Lack of Direct Effects of a Monoclonal Antibody Against Murine T‐Cell Suppressor Factor on Murine Embryo Development In Vitro

A frequency prediction method based on estimation of the ionospheric characteristics

Engineering next generation vascularized organoids

Subcellular Ilistribution of "Peripheral Type" Binding Sites for (3H)Ro5-4864 in Guinea Pig Lung

Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease

Effects of simulated acid rain and ozone on foliar chemistry of field-grown Pinus ponderosa seedlings and mature trees.

Angiorganoid: Vitalizing the Organoid with Blood Vessels.

Improving human cardiac organoid design using transcriptomics

A Hollow Fiber System for Simple Generation of Human Brain Organoids

Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture

3D Human iPSC Blood Vessel Organoids as a Source of Flow‐Adaptive Vascular Cells for Creating a Human‐Relevant 3D‐Scaffold Based Macrovessel Model

A patterned human primitive heart organoid model generated by pluripotent stem cell self-organization

Three-dimensional cardiac models: a pre-clinical testing platform

Advances in Cardiac Organoids

Longitudinal morphological and functional characterization of human heart organoids using optical coherence tomography

Biochemical characterization of gamma interferon-induced HLA-DR molecules expressed on the surface of human corneal fibroblasts.

Modeling acute myocardial infarction and cardiac fibrosis using human induced pluripotent stem cell-derived multi-cellular heart organoids

New Modalities of 3D Pluripotent Stem Cell-Based Assays in Cardiovascular Toxicity

Generating human bone marrow organoids for disease modeling and drug discovery

Generation of blood vessel organoids from human pluripotent stem cells

Vascularized Organoids: A More Complete Model